期刊文献+

阿魏酸钠对单侧输尿管梗阻大鼠肾脏保护作用的研究 被引量:2

Protective effect of Sodium Ferulate on rat kidney after unilateral ureteral obstruction
在线阅读 下载PDF
导出
摘要 目的探讨阿魏酸钠对大鼠单侧输尿管梗阻模型肾间质纤维化的影响。方法UUO大鼠给予阿魏酸钠100mg/(kg·d)腹腔注射,观察第14天血清肌酐、尿素氮的变化及肾间质纤维程度、ColⅠ、ColⅢ、t-PA、u-PA及PAI-1的表达。结果与UUO组相比,治疗组血清肌酐、尿素差异均无显著性,肾小管纤维化程度、PAI-1及Ⅰ、Ⅲ型胶原的表达显著降低,t-PA、u-PA的表达显著增加。结论阿魏酸钠可以通过下调PAI-1及上调t-PA、u-PA而减轻UUO术后大鼠肾间质纤维化。 [Objective] To investigate the effects of Sodium Ferulate on tubulointerstitial fibrosis of rat unilateral ureteral obstruction model. [Methods] Rats subjected to UUO were treatedwith daily peritoneal injection of 100 mg/kg of Sodium Ferulate. Creatinine, Urea nitrogen. The percentage of renal tubular lesion, interstitial fibrosis score were measured on 14th day after operation. The expression of t-PA, u-PA and PAI-1 were evaluated and compared. [Results] In comparison with UUO group, Creatinine, urea nitrogen were analogous, but the degree of renal tubulointerstitial fibrosis and interstitial expression of PAI-1, collagen Ⅰ and collagen Ⅲ were significantly reduced and interstitial expression of t-PA and u-PA were significantly increased. [Conclusion] Sodium Ferulate may play a protective role of the kidney by down-regulating PAI-1 and up- regulating t-PA and u-PA and alleviating renal interstitial fibrosis following UUO.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第3期344-347,共4页 China Journal of Modern Medicine
关键词 单侧输尿管梗阻 阿魏酸钠 纤溶酶原激活物 纤溶酶原激活物抑制剂-1 unilateral ureteral obstruction Sodium Fentlate plasminogen activator , plasminogen activator inhibitor-1
  • 相关文献

参考文献11

  • 1VIELHAUER V, ANDERS HJ, MACK M, et al. Obstructive nephropathy in the mouse: Progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2 and 5 positive leukecytes [.J]. J Am Soc Nephrol, 2001, 12: 1173-1187.
  • 2吴阶平.吴阶平泌尿外科学[MI.济南:山东科学技术出版社,2004:531-544.
  • 3HIRSCHBERG R, WANG S. Proteinuria and growth factors in the development of tubulointerstitial injury and scarring in kidney disease[J]. Curr Opin Nephrol Hypertens, 2005, 14(1): 43-52.
  • 4COCHRANE AL, KETT MM, SAMUEL CS, et al. Renal structural and functional repair in a mouse model of reversal of ureteral obstruction [J]. J Am Soc Nephrol, 2005, 16 (12): 3623-3630.
  • 5OKADA H, KALLURI R. Cellular and molecular pathways that lead to progression and regression of renal fibrogenesis [J]. Curr Mol Med, 2005, 5(5): 467-474.
  • 6ZHANG G, KIM H, CAI X, et al. Urokinase receptor diticiency accelerates renal fibrosis in obstructive nephropathy[J]. J Am Soc Neprol, 2003, 14(5): 1254-1271.
  • 7HERTIG A, BERROU J, ALLORY Y, et al. Type Ⅰ plasmlnogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivafivation of transforming growth factor beta[J]. FASEBJ, 2003, 17(13): 1904-1906.
  • 8KIMURA H. Increased expression of plasminogen activator inhibitor-1 in hypoxic renal injury and its pathological significance in progression of advanced renal disease[J]. Rinsho Byori, 2005, 53(8): 749-758.
  • 9IWAMOTO T, TAMAKI K. NAKAYAMA M, et al. Effect of endothelin 1 on fibrinolysis and plasminogen activator inhibitor 1 synthesis in rat mesangial cells[J]. Nephron, 1996, 73: 273-279.
  • 10PONTRELLI P, ROSSINI M, INFANTE B, et al. Rapamyein inhibits PAI-1 expression and reduces interstitial fibrosis and glomerulosclerosis in chronic aUograft nephropathy[J]. Transplantation, 2008, 85(1): 125-134.

同被引文献18

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部